A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis
NCT07299019 · RECRUITING · Phase 3
We track 1 ClinicalTrials.gov studies led by Zenas Biopharma Usa Llc. The portfolio skews toward Phase 3 (1 trials).
1 clinical trials sponsored by Zenas Biopharma Usa Llc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
Zenas Biopharma Usa Llc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.
Zenas Biopharma Usa Llc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Zenas Biopharma Usa Llc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.